The insulin signalling pathway is also critical in the process of ageing and Alzheimer’s disease (AD); insulin regulates brain glucose metabolism in the brain, but in AD, there is often reduced IR expression and tyrosine kinase signalling, resulting in defects in neuronal activity and cognitive function [12,14]. This evidence concerns the gene INS and Alzheimer disease.